Intracellular Working Capital vs. Total Asset

ITCI
 Stock
  

USD 54.22  1.37  2.59%   

For Intracellular profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intracellular to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intracellular Th utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intracellular's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intracellular Th over time as well as its relative position and ranking within its peers. Please see Risk vs Return Analysis.
  
Intracellular Price to Sales Ratio is most likely to increase significantly in the upcoming years. The last year's value of Price to Sales Ratio was reported at 50.75. The current Sales per Share is estimated to increase to 1.11, while Return on Sales is projected to decrease to (3.66) . The current Income Tax Expense is estimated to increase to 8,557, while Accumulated Other Comprehensive Income is projected to decrease to (392.7 K).

Intracellular Working Capital

379.9 Million

Is Intracellular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
B
Quarterly Revenue Growth YOY
2.24
Return On Assets
(0.28) 
Return On Equity
(0.51) 
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine Intracellular value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Intracellular Th Total Asset vs. Working Capital Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Intracellular's current stock value. Our valuation model uses many indicators to compare Intracellular value to that of its competitors to determine the firm's financial worth.
Intracellular Th is currently regarded as number one stock in working capital category among related companies. It is currently regarded as number one stock in total asset category among related companies fabricating about  1.22  of Total Asset per Working Capital. Intracellular Working Capital is most likely to increase significantly in the upcoming years. The last year's value of Working Capital was reported at 413.92 Million. Comparative valuation analysis is a catch-all model that can be used if you cannot value Intracellular by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intracellular's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intracellular's earnings, one of the primary drivers of an investment's value.

Intracellular Total Asset vs. Working Capital

Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Intracellular 
Working Capital 
 = 
Current Assets 
Current Liabilities 
401.13 M
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Intracellular 
Total Asset 
 = 
Tangible Assets 
Intangible Assets 
489.92 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Intracellular Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Intracellular, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Intracellular will eventually generate negative long term returns. The profitability progress is the general direction of Intracellular's change in net profit over the period of time. It can combine multiple indicators of Intracellular, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2022
Accumulated Other Comprehensive Income-364 K-392.7 K
Consolidated Income-284.1 M-291.6 M
Net Income-284.1 M-291.6 M
Net Income Common Stock-284.1 M-291.6 M
Operating Income-285.7 M-293.2 M
Preferred Dividends Income Statement Impact1.5 M1.5 M
Income Tax Expense5.6 K8.6 K
Net Income Per Employee-554.9 K-598.7 K

Intracellular Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Intracellular. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intracellular position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intracellular's important profitability drivers and their relationship over time.

Use Intracellular in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intracellular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will appreciate offsetting losses from the drop in the long position's value.

Intracellular Pair Trading

Intracellular Th Pair Trading Analysis

The ability to find closely correlated positions to Intracellular could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intracellular when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intracellular - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intracellular Th to buy it.
The correlation of Intracellular is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intracellular moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intracellular Th moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intracellular can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Intracellular position

In addition to having Intracellular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch
Please see Risk vs Return Analysis. Note that the Intracellular Th information on this page should be used as a complementary analysis to other Intracellular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Intracellular Stock analysis

When running Intracellular Th price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
To fully project Intracellular's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Intracellular Th at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Intracellular's income statement, its balance sheet, and the statement of cash flows.
Potential Intracellular investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Intracellular investors may work on each financial statement separately, they are all related. The changes in Intracellular's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intracellular's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.